Scarica l'app Stockscreener
14.25
1.38%
-0.20
Dopo l'orario di chiusura:
14.25
Precedente Chiudi:
$14.45
Aprire:
$14.83
Volume 24 ore:
2.51M
Relative Volume:
1.41
Capitalizzazione di mercato:
$2.18B
Reddito:
$363.55M
Utile/perdita netta:
$-78.68M
Rapporto P/E:
-28.50
EPS:
-0.5
Flusso di cassa netto:
$50.74M
1 W Prestazione:
+5.32%
1M Prestazione:
+32.81%
6M Prestazione:
+35.20%
1 anno Prestazione:
-14.82%
Intervallo 1D:
$14.16
$15.38
Intervallo di 1 settimana:
$13.43
$15.38
Portata 52W:
$8.635
$17.94
Certara Inc Stock (CERT) Company Profile
Nome
Certara Inc
Settore
Industria
Telefono
(415) 237-8272
Indirizzo
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
Confronta CERT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CERT
Certara Inc
|
14.25 | 2.18B | 363.55M | -78.68M | 50.74M | -0.50 |
|
VEEV
Veeva Systems Inc
|
220.53 | 35.90B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
54.22 | 9.90B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
86.08 | 7.46B | 1.15B | 96.70M | -161.99M | 1.09 |
|
TEM
Tempus Ai Inc
|
49.55 | 7.07B | 640.44M | -743.28M | -206.93M | -11.29 |
|
WAY
Waystar Holding Corp
|
36.80 | 6.32B | 906.14M | -52.62M | 89.62M | -0.3621 |
Certara Inc Stock (CERT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-27 | Iniziato | TD Cowen | Buy |
| 2024-09-27 | Aggiornamento | UBS | Neutral → Buy |
| 2024-04-10 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-04 | Iniziato | JMP Securities | Mkt Perform |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2023-12-07 | Iniziato | UBS | Neutral |
| 2023-12-05 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2023-08-22 | Downgrade | Jefferies | Buy → Hold |
| 2023-08-10 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-04-12 | Iniziato | Stephens | Overweight |
| 2023-04-03 | Downgrade | Barclays | Overweight → Equal Weight |
| 2022-12-14 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-09-08 | Iniziato | Berenberg | Buy |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-07-01 | Iniziato | Piper Sandler | Overweight |
| 2022-01-11 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-08-05 | Ripresa | Credit Suisse | Neutral |
| 2021-07-23 | Iniziato | Robert W. Baird | Outperform |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-01-06 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-01-05 | Iniziato | BofA Securities | Buy |
| 2021-01-05 | Iniziato | Credit Suisse | Neutral |
| 2021-01-05 | Iniziato | Jefferies | Hold |
| 2021-01-05 | Iniziato | William Blair | Outperform |
Mostra tutto
Certara Inc Borsa (CERT) Ultime notizie
Investing in Certara Inc (CERT): What You Must Know - knoxdaily.com
3 Momentum Stocks That Could Soar Post-Market Volatility - Investing.com
3 Momentum Stocks That Could Soar Post-Market Volatility - MarketBeat
Where are the Opportunities in (CERT) - news.stocktradersdaily.com
Geode Capital Management LLC Sells 10,953 Shares of Certara, Inc. (NASDAQ:CERT) - Defense World
Computer Aided Drug Discovery Market Future Prospects 2030 | Certara, Chemical Computing Group - openPR.com
LPL Financial LLC Increases Position in Certara, Inc. (NASDAQ:CERT) - Defense World
Will Certara (CERT) Beat Estimates Again in Its Next Earnings Report? - MSN
Certara, Inc. (NASDAQ:CERT) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Certara (NASDAQ:CERT) Stock Price Expected to Rise, KeyCorp Analyst Says - Defense World
Certara FY2025 EPS Estimate Increased by Leerink Partnrs - Defense World
Equities Analysts Set Expectations for Certara Q1 Earnings - Defense World
Leerink Partnrs Has Positive Outlook of Certara Q1 Earnings - Defense World
Certara Inc (CERT) Shares Gap Down to $13.69 on Apr 15 - GuruFocus
Certara expects Q1 sales above estimates - MSN
William Blair Analysts Lower Earnings Estimates for Certara - Defense World
Top 3 Health Care Stocks You May Want To Dump This Quarter - Benzinga
Certara, Inc.'s (NASDAQ:CERT) 32% Price Boost Is Out Of Tune With Revenues - simplywall.st
O Shaughnessy Asset Management LLC Has $138,000 Stake in Certara, Inc. (NASDAQ:CERT) - Defense World
Certara (CERT) Exceeds Revenue Expectations with Strong Q1 Growt - GuruFocus
Certara (CERT) Explores Strategic Options for Regulatory Services Unit | CERT Stock News - GuruFocus
Certara (CERT) Reaffirms 2025 Financial Projections | CERT Stock News - GuruFocus
Why Certara Inc. (CERT) Soared Last Week? - MSN
Why Certara Inc. (CERT) Skyrocketed On Monday? - MSN
Certara (CERT) Secures One-Year Lock-Up Agreement with Arsenal C - GuruFocus
Certara's Stock Soars on Strong Revenue Guidance and AI-Driven Innovations - GuruFocus
Certara (CERT) Reports Strong Growth in Q1 2024 Performance | CE - GuruFocus
Certara launches Non-Animal Navigator for drug development By Investing.com - Investing.com South Africa
Certara announces Q1 revenue growth and $100 million buyback By Investing.com - Investing.com South Africa
Certara Unveils $100 Million Buyback Plan In Better-Than-Expected Preliminary Earnings Report - Benzinga
Certara Launches Product for Biopharmaceutical Firms to Reduce Reliance on Animal Testing - marketscreener.com
Certara IncEntered Into Amendment To Previously Disclosed Letter Agreement Between Co And Arsenal Saturn Holdings Lp - MarketScreener
Certara Launches Non-Animal Navigator™ Solution to Help Drug Dev - GuruFocus
Certara announces Q1 revenue growth and $100 million buyback - Investing.com Australia
Certara (CERT) Introduces Non-Animal Navigator to Advance Precli - GuruFocus
Certara launches Non-Animal Navigator for drug development - Investing.com
Certara's Preliminary Q1 Revenue Increases; Reiterates 2025 Outlook; Authorizes $100 Million Share Buyback Plan - MarketScreener
Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing - MarketScreener
Certara Launches Non- Animal Navigator?? Solution to Help Drug Developers Reduce Reliance on Animal Testing - marketscreener.com
Certara Reports Preliminary First Quarter 2025 Financial Results; Announces $100 Million Share Repurchase Authorization - The Manila Times
These Mid-Cap Stocks Outshone The Market Volatility Last Week (Apr 7-Apr 11): Are These In Your Portfolio? - Benzinga
Robert W. Baird Raises Certara (NASDAQ:CERT) Price Target to $13.00 - Defense World
10 Firms Defy Market Slump, Record Double-Digit Gains Last Week - Insider Monkey
Certara Inc (CERT) Shares Up 18.36% on Apr 11 - GuruFocus
Certara (CERT) Receives Price Target Boost Following FDA Biosimu - GuruFocus
Certara Inc Azioni (CERT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.04%
1.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):